Companies by Sector - Pharmaceuticals and Biotechnology
| EPIC | Company | Index | Dividend Yield | Market Cap | Price Close | % Change |
|---|---|---|---|---|---|---|
| AZN | AstraZeneca | FTSE 100 | 1.55 | £234.48B | 15,118.00 | 1.72% |
| GSK | GSK | FTSE 100 | 3.31 | £86.98B | 2,144.00 | 0.99% |
| HLN | Haleon | FTSE 100 | 1.95 | £31.94B | 358.60 | 1.73% |
| HIK | Hikma Pharmaceuticals | FTSE 100 | 4.72 | £3B | 1,379.00 | 2.68% |
| HCM | Hutchmed China | AIM | £1.89B | 220.00 | 4.80% | |
| GNS | Genus | FTSE 250 | 1.24 | £1.76B | 2,644.00 | -0.08% |
| INDV | Indivior | FTSE 250 | £1.54B | 1,238.00 | -3.10% | |
| OXB | Oxford BioMedica | FTSE Small Cap | £774.97M | 641.00 | 3.39% | |
| AGY | Allergy Therapeutics | AIM | £683.91M | 10.80 | -2.50% | |
| PRTC | Puretech Health | FTSE Small Cap | £322.29M | 132.40 | 0.61% | |
| AVCT | Avacta Group | AIM | £317.29M | 70.00 | -7.00% | |
| BTG | BTG | AIM | 3.78 | £187.81M | 116.50 | -0.10% |
| ANCR | Animalcare Group | AIM | 2.12 | £169.16M | 245.00 | -2.60% |
| MXCT | Maxcyte Inc | AIM | £161.75M | 147.69 | -1.20% | |
| DXRX | Diaceutics | AIM | £136.72M | 160.00 | -0.50% | |
| BMK | Benchmark Holdings | AIM | £135.69M | 22.05 | 1.50% | |
| SCLP | Scancell Holdings | AIM | £129.72M | 12.50 | -1.10% | |
| STX | Shield Therapeutics | AIM | £100.86M | 9.44 | -7.90% | |
| ANP | Anpario | AIM | 2.66 | £96.8M | 475.00 | -0.90% |
| BVXP | Bioventix | AIM | 8.11 | £96.66M | 1,890.00 | -2.20% |
| 4BB | 4basebio | AIM | £79.71M | 529.70 | -0.40% | |
| ANIC | Agronomics | AIM | £70.26M | 6.63 | -0.60% | |
| EAH | Eco Animal Health Group | AIM | £59.63M | 88.00 | -4.30% | |
| OBI | Ondine Biomedical Inc | AIM | £57.15M | 11.02 | 2.60% | |
| HVO | Hvivo | AIM | 2.65 | £51.37M | 7.43 | -5.10% |
| FARN | Faron Pharmaceuticals OY | AIM | £50.37M | 43.50 | 1.10% | |
| ABDX | Abingdon Health | AIM | £34.67M | 7.85 | 2.60% | |
| IMM | ImmuPharma | AIM | £30.88M | 4.95 | -3.00% | |
| POLB | Poolbeg Pharma | AIM | £29.61M | 4.20 | -2.10% | |
| EDEN | Eden Research | AIM | £26.11M | 3.30 | -2.40% | |
| SBTX | SkinBioTherapeutics | AIM | £25.27M | 9.75 | -14.90% | |
| AREC | Arecor Therapeutics | AIM | £24.35M | 62.00 | -1.30% | |
| SAR | Sareum Holdings | AIM | £22.09M | 16.00 | -5.60% | |
| GDR | Genedrive | AIM | £15.25M | 0.93 | -1.60% | |
| CEL | Celadon Pharmaceuticals | AIM | £9.23M | 13.40 | % | |
| OBD | Oxford BioDynamics | AIM | £8.15M | 0.19 | -4.00% | |
| AGL | Angle | AIM | £7.72M | 2.40 | -0.70% | |
| VRCI | Verici Dx | AIM | £7.19M | 0.47 | -4.80% | |
| IXI | Ixico | AIM | £6.83M | 7.32 | -1.50% | |
| FUM | Futura Medical | AIM | £6.78M | 1.16 | 14.60% | |
| OPTI | OptiBiotix Health | AIM | £5.63M | 5.24 | -3.30% | |
| PRM | Proteome Sciences | AIM | £5.54M | 1.58 | 8.00% | |
| TRX | Tissue Regenix Group | AIM | £5.16M | 7.25 | -1.50% | |
| VAL | ValiRx | AIM | £2.3M | 0.31 | -2.20% | |
| GUN | Gunsynd | AIM | £1.55M | 0.10 | 9.50% |